- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
You are here
Webinar: Ad26 Mosaic Program—Janssen’s Maria Pau discusses preparations for the next efficacy trial
April 28, 2017
The HIV Vaccine Awareness Day 2017 webinar series kicked off with an overview of the Ad26/mosaic vaccine efficacy program from Janssen’s Maria Grazia Pau. This strategy is notable both for the science and for the active leadership from industry. Dr. Pau did a terrific job of explaining where the strategy fits into the broader vaccine field.
Recording Available: YouTube / Audio / Slides
This was one in a series of HIV Vaccine Awareness Day webinars. For details on all other calls, including recordings, visit here.